Parkinsonism with Normal Dopaminergic Presynaptic Terminals in Cerebrotendinous Xanthomatosis
- PMID: 31970228
- PMCID: PMC6962677
- DOI: 10.1002/mdc3.12846
Parkinsonism with Normal Dopaminergic Presynaptic Terminals in Cerebrotendinous Xanthomatosis
Keywords: cerebrotendinous xanthomatosis; dopaminergic presynaptic terminals; iron deposition; parkinsonian syndrome.
Conflict of interest statement
This study was funded by the Beijing Municipal Administration of Hospitals’ Mission Plan (Grant SML20150803), the Beijing Municipal Science & Technology Commission (Grant Z171100000117013), and the National Key R&D Program of China (Grants 2017YFC0840105 and 2018YFC1312000). The authors declare that there are no conflicts of interest relevant to this work.
Figures

References
-
- Stelten BML, Warrenburg BPCVD, Wevers RA, Verrips A. Movement disorders in cerebrotendinous xanthomatosis. Parkinsonism Relat Disord 2019;58:12–16. - PubMed
-
- Makary MS, Kisanuki YY, Amin NN, Slone HW. Teaching neuroimages: cerebrotendinous xanthomatosis: a rare treatable adult‐onset lipid storage disease. Neurology 2018;90(7):e637–e638. - PubMed
-
- Brar S, Henderson D, Schenck J, Zimmerman EA. Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism. JAMA Neurology 2009;66(3):371–374. - PubMed
-
- Hider RC, Longo DL, Hoffbrand AV. The role of deferiprone in iron chelation. N Engl J Med 2018;379(22):2140–2150. - PubMed
LinkOut - more resources
Full Text Sources